Myths about diversity in clinical trials reduce return on investment for industry
Mohammed S. Chaudhry, Jessica Spahn, Shilpen Patel, Charles S. Fuchs, Jennifer Lauchle, Nikheel S. Kolatkar, Nicole Richie, Quita Highsmith, Meghan E. McKenzie, Ruma Bhagat
Topics & Concepts
Diversity (politics)Investment (military)MythologyClinical trialReturn on investmentBusinessMedicineIntensive care medicineEconomicsInternal medicineHistoryPolitical scienceProduction (economics)PoliticsMacroeconomicsLawClassicsScience, Research, and MedicineBiomedical Ethics and RegulationHealth and Medical Research Impacts